ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates includ...
Leadership
Richard A. Heyman Ph.D.Founder
Founder, Independent Chairman & Member of Scientific Advisory Board
